Sponsor Pipeline

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07628855 A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection… HNPCC Not Yet Recruiting
Phase 1/2
NCT06776757 Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for… Metastatic Colorectal Cancer Recruiting
NCT06776770 A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in… Gastric Cancer Recruiting
Early Phase 1
NCT07182435 Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With… Solid Tumor Malignancies Not Yet Recruiting
Not specified
NCT06990178 Adaptive Neoadjuvant Therapy for Esophageal Cancer Esophageal Carcinoma Enrolling by Invitation
Disease Areas
Get alerts when Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free